Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Question for Eoganacht

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon May 12, 2023 3:54pm

163 Views

Post# 35446184

RE:RE:RE:Question for Eoganacht

Not sure exactly what the question is.

Enrolled is the ones that started and got the treatment.
Responders are the subset that responded.
Then a portion of the responders kept the response.

Durable response is a definition I've never liked based on how it is used.

Keep in mind that it also get confusing since some will use percent of "evaluable patients".

Eog may be able to make the best tables.....

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?